Lorenz Roger Van der Linden (Lorenz Van der Linden, Lorenz Van Der Linden)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 40

Top Venues

European journal of hospital pharmacy : science and practice

Drugs & aging

Clinical pharmacokinetics

The AAPS journal

University Hospitals Leuven

KU Leuven (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University Hospitals Leuven Oct 01 2010

Belgium

Hospital Pharmacist :: Hospital Pharmacy

Education History

KU Leuven Oct 01 2013 - Sep 27 2018

Belgium

PHD :: PhD in Biomedical Sciences

Publications

Angela Elma Edwina, Erwin Dreesen, Matthias Gijsen, Helena Cornelia van den Hout, Stefanie Desmet, Johan Flamaing, Lorenz Roger Van der Linden, Isabel Spriet, Jos Tournoy
Decreased Kidney Function Explains Higher Vancomycin Exposure in Older Adults. Drugs & aging (2024)
Esther Vanderstuyft, Julie Hias, Laura Hellemans, Lucas Van Aelst, Jos Tournoy, Lorenz Roger Van der Linden
Appropriateness of antithrombotics in geriatric inpatients with atrial fibrillation: a retrospective, cross-sectional study. European journal of hospital pharmacy : science and practice (2024)
Lise Defieuw, Julie Hias, Fatma Karapinar-Carkıt, Paul Forsyth, Lorenz Roger Van der Linden
Empowering European hospital pharmacists in the face of heart failure. European journal of hospital pharmacy : science and practice 31 (4) (2024)
Angela Elma Edwina, Erwin Dreesen, Julie Hias, Birgit C P Koch, Nele Van den Eede, Steven Pauwels, Karel Allegaert, Lorenz Roger Van der Linden, Isabel Spriet, Jos Tournoy
Agreement Between a Colorimetric Assay and Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry for Quantifying Paracetamol Plasma Concentrations. The AAPS journal 26 (1) (2024)
Angela Elma Edwina, Erwin Dreesen, Julie Hias, Birgit C P Koch, Nele Van den Eede, Steven Pauwels, Karel Allegaert, Lorenz Roger Van der Linden, Isabel Spriet, Jos Tournoy
Agreement Between a Colorimetric Assay and Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry for Quantifying Paracetamol Plasma Concentrations. The AAPS journal 26 (1) (2024)
Lorenz Roger Van der Linden, Thomas Vanassche, Lucas Van Aelst, Peter Verhamme
Comment on: Anti-Coagulant Treatment of Cancer-Associated Thrombosis in Frail Patients: Impact of Frailties on the Management of Drug-Drug Interactions. Clinical pharmacokinetics 63 (3) (2024)
Lorenz Roger Van der Linden, Fatma Karapinar-Carkıt, Paul Forsyth
The pharmacist ally in heart failure: Useful when involved. Letter regarding the article 'Effective medications can work only in patients who take them: Implications for post-acute heart failure care'. European journal of heart failure (2024)
Angela Elma Edwina, Erwin Dreesen, Julie Hias, Birgit C P Koch, Nele Van den Eede, Steven Pauwels, Karel Allegaert, Lorenz Roger Van der Linden, Isabel Spriet, Jos Tournoy
Agreement Between a Colorimetric Assay and Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry for Quantifying Paracetamol Plasma Concentrations. The AAPS journal 26 (1) (2024)
Angela Elma Edwina, Erwin Dreesen, Julie Hias, Birgit C P Koch, Nele Van den Eede, Steven Pauwels, Karel Allegaert, Lorenz Roger Van der Linden, Isabel Spriet, Jos Tournoy
Agreement Between a Colorimetric Assay and Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry for Quantifying Paracetamol Plasma Concentrations. The AAPS journal 26 (1) (2024)
Lorenz Roger Van der Linden, Jos Tournoy
Prevalence and trends in polypharmacy and excessive polypharmacy: a retrospective national database analysis (2012-2021). International journal of clinical pharmacy (2024)
Lise Defieuw, Julie Hias, Fatma Karapinar-Carkıt, Paul Forsyth, Lorenz Roger Van der Linden
Empowering European hospital pharmacists in the face of heart failure. European journal of hospital pharmacy : science and practice 31 (4) (2024)
Lorenz Roger Van der Linden, Thomas Vanassche, Lucas Van Aelst, Peter Verhamme
Comment on: Anti-Coagulant Treatment of Cancer-Associated Thrombosis in Frail Patients: Impact of Frailties on the Management of Drug-Drug Interactions. Clinical pharmacokinetics 63 (3) (2024)
Lorenz Roger Van der Linden, Thomas Vanassche, Lucas Van Aelst, Peter Verhamme
Comment on: Anti-Coagulant Treatment of Cancer-Associated Thrombosis in Frail Patients: Impact of Frailties on the Management of Drug-Drug Interactions. Clinical pharmacokinetics (2024)
Lise Defieuw, Julie Hias, Fatma Karapinar-Carkıt, Paul Forsyth, Lorenz Roger Van der Linden
Empowering European hospital pharmacists in the face of heart failure. European journal of hospital pharmacy : science and practice 31 (4) (2024)
Lorenz Roger Van der Linden, Thomas Vanassche, Lucas Van Aelst, Peter Verhamme
Comment on: Anti-Coagulant Treatment of Cancer-Associated Thrombosis in Frail Patients: Impact of Frailties on the Management of Drug-Drug Interactions. Clinical pharmacokinetics 63 (3) (2024)
Lorenz Roger Van der Linden, Fatma Karapinar-Carkıt, Paul Forsyth
The pharmacist ally in heart failure: Useful when involved. Letter regarding the article 'Effective medications can work only in patients who take them: Implications for post-acute heart failure care'. European journal of heart failure 26 (5) (2024)
Lise Defieuw, Julie Hias, Fatma Karapinar-Carkıt, Paul Forsyth, Lorenz Roger Van der Linden
Empowering European hospital pharmacists in the face of heart failure. European journal of hospital pharmacy : science and practice (2024)
Lorenz Roger Van der Linden, Jos Tournoy
Prevalence and trends in polypharmacy and excessive polypharmacy: a retrospective national database analysis (2012-2021). International journal of clinical pharmacy 46 (4) (2024)
Lorenz Roger Van der Linden, Fatma Karapinar-Carkıt, Paul Forsyth
The pharmacist ally in heart failure: Useful when involved. Letter regarding the article 'Effective medications can work only in patients who take them: Implications for post-acute heart failure care'. European journal of heart failure 26 (5) (2024)
Lorenz Roger Van der Linden, Thomas Vanassche, Eric Van Cutsem, Lucas Van Aelst, Peter Verhamme
Pharmacokinetic drug-drug interactions with direct anticoagulants in the management of cancer-associated thrombosis. British journal of clinical pharmacology (2023)
Lorenz Roger Van der Linden, Jens Neefs, Thomas Vanassche, Robin Lemmens, Peter Verhamme
From bad to worse: the shortage of fibrinolytics. European journal of hospital pharmacy : science and practice (2023)
Lorenz Roger Van der Linden, Julie Hias, Karolien Walgraeve, Mirko Petrovic, Jos Tournoy, Christophe Vandenbriele, Lucas Van Aelst
Guideline-Directed Medical Therapies for Heart Failure with a Reduced Ejection Fraction in Older Adults: A Narrative Review on Efficacy, Safety and Timeliness. Drugs & aging (2023)
Lorenz Roger Van der Linden, Thomas Vanassche, Eric Van Cutsem, Lucas Van Aelst, Peter Verhamme
Pharmacokinetic drug-drug interactions with direct anticoagulants in the management of cancer-associated thrombosis. British journal of clinical pharmacology (2023)
Angela Elma Edwina, Nada Dia, Erwin Dreesen, Thomas Vanassche, Peter Verhamme, Isabel Spriet, Lorenz Roger Van der Linden, Jos Tournoy
Insights into the Pharmacokinetics and Pharmacodynamics of Direct Oral Anticoagulants in Older Adults with Atrial Fibrillation: A Structured Narrative Review. Clinical pharmacokinetics (2023)
Lorenz Roger Van der Linden, Julie Hias, Astrid Liesenborghs, Karolien Walgraeve, Pieter Van Brantegem, Laura Hellemans, Koen Milisen, Jos Tournoy
The impact of a pharmacist intervention on post-discharge hypnotic drug discontinuation in geriatric inpatients: a before-after study. BMC geriatrics 23 (1) (2023)
Julie Hias, Laura Hellemans, Karolien Walgraeve, Jos Tournoy, Christophe Vandenbriele, Lucas Van Aelst, Lorenz Roger Van der Linden
Should vericiguat be initiated in geriatric inpatients with heart failure with reduced ejection fraction and a worsening heart failure event prior to discharge? European journal of hospital pharmacy : science and practice (2022)
Lorenz Roger Van der Linden, Julie Hias, Karolien Walgraeve, Jos Tournoy, Lucas Van Aelst, Christophe Vandenbriele
Estimating the Time to Benefit for Therapies in Heart Failure with Reduced Ejection Fraction: A Case Study of Sacubitril-Valsartan Using Reconstructed Data from a Randomized Controlled Trial. Drugs & aging (2022)
Irina Dumitrescu, Minne Casteels, Kristel De Vliegher, Lorenz Roger Van der Linden, Ellen Van Leeuwen, Tinne Dilles
High-Risk Medication in Home Care Nursing: A Delphi Study. Journal of patient safety 18 (5) (2022)
Julie Hias, Laura Hellemans, Karolien Walgraeve, Jos Tournoy, Lorenz Roger Van der Linden
SGLT2 Inhibitors in Older Adults with Heart Failure with Preserved Ejection Fraction. Drugs & aging 39 (3) (2022)
Laura Hellemans, Julie Hias, Sabrina De Winter, Karolien Walgraeve, Jos Tournoy, Lorenz Roger Van der Linden
Importance of medication reconciliation, even in the absence of positive data. European journal of hospital pharmacy : science and practice (2021)
Laura Hellemans, Beatrijs Mertens, Julie Hias, Jos Tournoy, Lorenz Roger Van der Linden
Age is just a number: the concept of time to benefit in older adults. European journal of hospital pharmacy : science and practice (2021)
Lorenz Roger Van der Linden, Julie Hias, Karolien Walgraeve, Johan Flamaing, Jos Tournoy, Isabel Spriet
Clinical Pharmacy Services in Older Inpatients: An Evidence-Based Review. Drugs & aging 37 (3) (2020)
Greet Van De Sijpe, Charlotte Quintens, Isabel Spriet, Lorenz Roger Van der Linden
Preventing medication-related harm: Perfect is the enemy of the good. British journal of clinical pharmacology 87 (7) (2020)
Julie Hias, Lorenz Roger Van der Linden, Karolien Walgraeve, Jean-Claude Lemper, Laura Hellemans, Isabel Spriet, Jos Tournoy
Optimizing pharmacotherapy on geriatric hospital units in Belgium - a national survey. Acta clinica Belgica (2020)
Lorenz Roger Van der Linden, Julie Hias, Karolien Walgraeve, Silke Loyens, Johan Flamaing, Isabel Spriet, Jos Tournoy
Factors associated with the number of clinical pharmacy recommendations: findings from an observational study in geriatric inpatients. Acta clinica Belgica 76 (2) (2019)
Lorenz Roger Van der Linden, Julie Hias, Karolien Walgraeve, Johan Flamaing, Isabel Isabel Spriet, Jos Tournoy
Introduction to Bayesian statistics: a practical framework for clinical pharmacists. European journal of hospital pharmacy : science and practice 28 (6) (2019)
Lorenz Roger Van der Linden, Liesbeth Decoutere, Leen Beerten, Toon Delva, Isabel Spriet, Johan Flamaing, Jos Tournoy
External validation of a clinical pharmacy intervention in geriatric inpatients: a controlled study. International journal of clinical pharmacy 41 (4) (2019)
Julie Hias, Karolien Walgraeve, Jos Tournoy, Johan Flamaing, Isabel Spriet, Lorenz Roger Van der Linden
Physician's feedback on a clinical pharmacy program on geriatric wards. Acta clinica Belgica 75 (5) (2019)
Lorenz Roger Van der Linden, Julie Hias, Lisa Dreessen, Koen Milisen, Johan Flamaing, Isabel Spriet, Jos Tournoy
Medication review versus usual care to improve drug therapies in older inpatients not admitted to geriatric wards: a quasi-experimental study (RASP-IGCT). BMC geriatrics 18 (1) (2018)
Lorenz Roger Van der Linden, Julie Hias, Karolien Walgraeve, Johan Flamaing, Isabel Spriet, Jos Tournoy
Clinical Pharmacy Services on Geriatric Care Wards: Catch 22 of Implementation and Research. Drugs & aging 35 (5) (2018)

Lorenz Roger Van der Linden.css-eqlu8i{font-size:small;padding-left:4px;} (Lorenz Van der Linden, Lorenz Van Der Linden)

Publication Activity (10 Years)

Top Topics

Top Venues

Lorenz Roger Van der Linden (Lorenz Van der Linden, Lorenz Van Der Linden)